IPI≥2
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma (NCT00499018) | Fondazione Italiana Linfomi - ETS | 2006-01-01 |
Track IPI≥2 automatically
Every clearance here is in the API, with alerts when new ones post.